The 12-week BBM Pilot, run by Dave Letele and Gareth O’Donnell , showed immediate results for a group of at risk participants. Have a look at the critical insights below.
The blood panels conducted were:
• Fasting Insulin • Lipids Panel
​
These panels were conducted as primarily health and safety measures to identify high risk individuals within the group as well as key medical markers for improvement. There were eight individuals who were above healthy norms or currently under medical guidance for diabetes.
10 individuals were outside of healthy norms for cholesterol. These individual were advised to report to their doctor for on-going health monitoring as part of the care plan. The high risk individuals were targeted for return blood test upon completion of the course. The results are as shown below:
​
​